122 related articles for article (PubMed ID: 31696949)
1. The papillomavirus E5 gene does not affect EGFR transcription and overall survival in cervical cancer.
Basto DL; Chaves CBP; Felix SP; Amaro-Filho SM; Vieira VC; Martins LFL; de Carvalho NA; Almeida LM; Moreira MÂM
J Med Virol; 2020 Aug; 92(8):1283-1289. PubMed ID: 31696949
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt.
Kim SH; Juhnn YS; Kang S; Park SW; Sung MW; Bang YJ; Song YS
Cell Mol Life Sci; 2006 Apr; 63(7-8):930-8. PubMed ID: 16596339
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor-dependent stimulation of differentiation by human papillomavirus type 16 E5.
Trammel J; Amusan O; Hultgren A; Raikhy G; Bodily JM
Virology; 2024 Feb; 590():109952. PubMed ID: 38103269
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance.
Scott ML; Woodby BL; Ulicny J; Raikhy G; Orr AW; Songock WK; Bodily JM
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666385
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
[TBL] [Abstract][Full Text] [Related]
6. Suppression of human papillomavirus type 16 E5 oncoprotein: A promising step in fostering the treatment of cervical cancer.
Hemmat N; Doustvandi MA; Asadzadeh Z; Mokhtarzadeh A; Baradaran B; Baghi HB
Oncol Res; 2021; 29(2):141-148. PubMed ID: 37305401
[TBL] [Abstract][Full Text] [Related]
7. Variable expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancer.
Um SH; Mundi N; Yoo J; Palma DA; Fung K; MacNeil D; Wehrli B; Mymryk JS; Barrett JW; Nichols AC
J Clin Virol; 2014 Sep; 61(1):94-100. PubMed ID: 25027574
[TBL] [Abstract][Full Text] [Related]
8. Impact of HPV E5 on viral life cycle via EGFR signaling.
Ilahi NE; Bhatti A
Microb Pathog; 2020 Feb; 139():103923. PubMed ID: 31836496
[TBL] [Abstract][Full Text] [Related]
9. Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome.
Lu X; Jiang L; Zhang L; Zhu Y; Hu W; Wang J; Ruan X; Xu Z; Meng X; Gao J; Su X; Yan F
Neoplasia; 2019 Jun; 21(6):591-601. PubMed ID: 31055200
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment.
Kim MK; Kim HS; Kim SH; Oh JM; Han JY; Lim JM; Juhnn YS; Song YS
Biochem Pharmacol; 2010 Dec; 80(12):1930-5. PubMed ID: 20643111
[TBL] [Abstract][Full Text] [Related]
11. E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis.
Zhang B; Spandau DF; Roman A
J Virol; 2002 Jan; 76(1):220-31. PubMed ID: 11739687
[TBL] [Abstract][Full Text] [Related]
12. HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer.
Amaro-Filho SM; Pereira Chaves CB; Felix SP; Basto DL; de Almeida LM; Moreira MAM
Papillomavirus Res; 2018 Jun; 5():172-179. PubMed ID: 29649654
[TBL] [Abstract][Full Text] [Related]
13. [Effects of human papillomavirus 16 E5 on malignancy of human cervical cancer cells and the mechanism there of].
Liao SJ; Deng DR; Xia X
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(43):3080-4. PubMed ID: 19192411
[TBL] [Abstract][Full Text] [Related]
14. The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix.
Chang JL; Tsao YP; Liu DW; Huang SJ; Lee WH; Chen SL
J Biomed Sci; 2001; 8(2):206-13. PubMed ID: 11287752
[TBL] [Abstract][Full Text] [Related]
15. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma.
Peta E; Cappellesso R; Masi G; Sinigaglia A; Trevisan M; Grassi A; Di Camillo B; Vassarotto E; Fassina A; Palù G; Barzon L
Hum Pathol; 2017 Mar; 61():33-40. PubMed ID: 27818285
[TBL] [Abstract][Full Text] [Related]
17. The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients.
Taberna M; Torres M; Alejo M; Mena M; Tous S; Marquez S; Pavón MA; León X; García J; Guix M; Hijano R; Bonfill T; Aguilà A; Lozano A; Mesía R; Alemany L; Bravo IG
Front Oncol; 2018; 8():589. PubMed ID: 30619735
[No Abstract] [Full Text] [Related]
18. E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line.
Wechsler EI; Tugizov S; Herrera R; Da Costa M; Palefsky JM
J Gen Virol; 2018 May; 99(5):631-644. PubMed ID: 29624161
[TBL] [Abstract][Full Text] [Related]
19. Situation of HPV16 E2 gene status during radiotherapy treatment of cervical carcinoma.
Kahla S; Kochbati L; Maalej M; Oueslati R
Asian Pac J Cancer Prev; 2014; 15(6):2869-73. PubMed ID: 24761916
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus does not have a causal role in colorectal carcinogenesis.
Lorenzon L; Mazzetta F; Pilozzi E; Uggeri G; Torrisi MR; Ferri M; Ziparo V; French D
World J Gastroenterol; 2015 Jan; 21(1):342-50. PubMed ID: 25574110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]